Our previous study has revealed that the population of CD4+LAP+ cells was increased in the peripheral blood of colorectal cancer (CRC) patients; moreover, these cells demonstrated a TGF-β–dependent suppressive phenotype [29]. This evidence concerns the gene CD4 and colorectal carcinoma.